[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Acute Intermittent Porphyria Market Growth 2018-2023

October 2018 | 133 pages | ID: G360AA0DE41EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Acute intermittent porphyria (AIP) is a genetic metabolic disorder affecting the production of heme, the oxygen-binding prosthetic group of hemoglobin. It is characterized by a deficiency of the enzyme porphobilinogen deaminase.
Over the next five years, LPI(LP Information) projects that Acute Intermittent Porphyria will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Acute Intermittent Porphyria market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Acute Intermittent Porphyria market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Gonadotropin-Releasing Hormone Analogues
  • Prophylactic Hematin Infusions
Segmentation by application:
  • Hospitals & Clinics
  • Research Centers
This report also splits the market by region:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Dahaner
  • Roche
  • Bio-Rad Laboratories
  • Siemens
  • ARKRAY
  • Sysmex Corporation
  • ACON Laboratories
  • ...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Acute Intermittent Porphyria consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Acute Intermittent Porphyria market by identifying its various subsegments.
  • Focuses on the key global Acute Intermittent Porphyria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Acute Intermittent Porphyria with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Acute Intermittent Porphyria submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Acute Intermittent Porphyria Consumption 2013-2023
  2.1.2 Acute Intermittent Porphyria Consumption CAGR by Region
2.2 Acute Intermittent Porphyria Segment by Type
  2.2.1 Gonadotropin-Releasing Hormone Analogues
  2.2.2 Prophylactic Hematin Infusions
2.3 Acute Intermittent Porphyria Consumption by Type
  2.3.1 Global Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
  2.3.2 Global Acute Intermittent Porphyria Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Acute Intermittent Porphyria Sale Price by Type (2013-2018)
2.4 Acute Intermittent Porphyria Segment by Application
  2.4.1 Hospitals & Clinics
  2.4.2 Research Centers
2.5 Acute Intermittent Porphyria Consumption by Application
  2.5.1 Global Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
  2.5.2 Global Acute Intermittent Porphyria Value and Market Share by Application (2013-2018)
  2.5.3 Global Acute Intermittent Porphyria Sale Price by Application (2013-2018)

3 GLOBAL ACUTE INTERMITTENT PORPHYRIA BY PLAYERS

3.1 Global Acute Intermittent Porphyria Sales Market Share by Players
  3.1.1 Global Acute Intermittent Porphyria Sales by Players (2016-2018)
  3.1.2 Global Acute Intermittent Porphyria Sales Market Share by Players (2016-2018)
3.2 Global Acute Intermittent Porphyria Revenue Market Share by Players
  3.2.1 Global Acute Intermittent Porphyria Revenue by Players (2016-2018)
  3.2.2 Global Acute Intermittent Porphyria Revenue Market Share by Players (2016-2018)
3.3 Global Acute Intermittent Porphyria Sale Price by Players
3.4 Global Acute Intermittent Porphyria Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Acute Intermittent Porphyria Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Acute Intermittent Porphyria Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 ACUTE INTERMITTENT PORPHYRIA BY REGIONS

4.1 Acute Intermittent Porphyria by Regions
  4.1.1 Global Acute Intermittent Porphyria Consumption by Regions
  4.1.2 Global Acute Intermittent Porphyria Value by Regions
4.2 Americas Acute Intermittent Porphyria Consumption Growth
4.3 APAC Acute Intermittent Porphyria Consumption Growth
4.4 Europe Acute Intermittent Porphyria Consumption Growth
4.5 Middle East & Africa Acute Intermittent Porphyria Consumption Growth

5 AMERICAS

5.1 Americas Acute Intermittent Porphyria Consumption by Countries
  5.1.1 Americas Acute Intermittent Porphyria Consumption by Countries (2013-2018)
  5.1.2 Americas Acute Intermittent Porphyria Value by Countries (2013-2018)
5.2 Americas Acute Intermittent Porphyria Consumption by Type
5.3 Americas Acute Intermittent Porphyria Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Acute Intermittent Porphyria Consumption by Countries
  6.1.1 APAC Acute Intermittent Porphyria Consumption by Countries (2013-2018)
  6.1.2 APAC Acute Intermittent Porphyria Value by Countries (2013-2018)
6.2 APAC Acute Intermittent Porphyria Consumption by Type
6.3 APAC Acute Intermittent Porphyria Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Acute Intermittent Porphyria by Countries
  7.1.1 Europe Acute Intermittent Porphyria Consumption by Countries (2013-2018)
  7.1.2 Europe Acute Intermittent Porphyria Value by Countries (2013-2018)
7.2 Europe Acute Intermittent Porphyria Consumption by Type
7.3 Europe Acute Intermittent Porphyria Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Acute Intermittent Porphyria by Countries
  8.1.1 Middle East & Africa Acute Intermittent Porphyria Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Acute Intermittent Porphyria Value by Countries (2013-2018)
8.2 Middle East & Africa Acute Intermittent Porphyria Consumption by Type
8.3 Middle East & Africa Acute Intermittent Porphyria Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Acute Intermittent Porphyria Distributors
10.3 Acute Intermittent Porphyria Customer

11 GLOBAL ACUTE INTERMITTENT PORPHYRIA MARKET FORECAST

11.1 Global Acute Intermittent Porphyria Consumption Forecast (2018-2023)
11.2 Global Acute Intermittent Porphyria Forecast by Regions
  11.2.1 Global Acute Intermittent Porphyria Forecast by Regions (2018-2023)
  11.2.2 Global Acute Intermittent Porphyria Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Acute Intermittent Porphyria Forecast by Type
11.8 Global Acute Intermittent Porphyria Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Dahaner
  12.1.1 Company Details
  12.1.2 Acute Intermittent Porphyria Product Offered
  12.1.3 Dahaner Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Dahaner News
12.2 Roche
  12.2.1 Company Details
  12.2.2 Acute Intermittent Porphyria Product Offered
  12.2.3 Roche Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Roche News
12.3 Bio-Rad Laboratories
  12.3.1 Company Details
  12.3.2 Acute Intermittent Porphyria Product Offered
  12.3.3 Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Bio-Rad Laboratories News
12.4 Siemens
  12.4.1 Company Details
  12.4.2 Acute Intermittent Porphyria Product Offered
  12.4.3 Siemens Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Siemens News
12.5 ARKRAY
  12.5.1 Company Details
  12.5.2 Acute Intermittent Porphyria Product Offered
  12.5.3 ARKRAY Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 ARKRAY News
12.6 Sysmex Corporation
  12.6.1 Company Details
  12.6.2 Acute Intermittent Porphyria Product Offered
  12.6.3 Sysmex Corporation Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Sysmex Corporation News
12.7 ACON Laboratories
  12.7.1 Company Details
  12.7.2 Acute Intermittent Porphyria Product Offered
  12.7.3 ACON Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 ACON Laboratories News

13 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Figure Picture of Acute Intermittent Porphyria
Table Product Specifications of Acute Intermittent Porphyria
Figure Acute Intermittent Porphyria Report Years Considered
Figure Market Research Methodology
Figure Global Acute Intermittent Porphyria Consumption Growth Rate 2013-2023 (K Units)
Figure Global Acute Intermittent Porphyria Value Growth Rate 2013-2023 ($ Millions)
Table Acute Intermittent Porphyria Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Gonadotropin-Releasing Hormone Analogues
Table Major Players of Gonadotropin-Releasing Hormone Analogues
Figure Product Picture of Prophylactic Hematin Infusions
Table Major Players of Prophylactic Hematin Infusions
Table Global Consumption Sales by Type (2013-2018)
Table Global Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Figure Global Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Table Global Acute Intermittent Porphyria Revenue by Type (2013-2018) ($ million)
Table Global Acute Intermittent Porphyria Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Acute Intermittent Porphyria Value Market Share by Type (2013-2018)
Table Global Acute Intermittent Porphyria Sale Price by Type (2013-2018)
Figure Acute Intermittent Porphyria Consumed in Hospitals & Clinics
Figure Global Acute Intermittent Porphyria Market: Hospitals & Clinics (2013-2018) (K Units)
Figure Global Acute Intermittent Porphyria Market: Hospitals & Clinics (2013-2018) ($ Millions)
Figure Global Hospitals & Clinics YoY Growth ($ Millions)
Figure Acute Intermittent Porphyria Consumed in Research Centers
Figure Global Acute Intermittent Porphyria Market: Research Centers (2013-2018) (K Units)
Figure Global Acute Intermittent Porphyria Market: Research Centers (2013-2018) ($ Millions)
Figure Global Research Centers YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Figure Global Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Table Global Acute Intermittent Porphyria Value by Application (2013-2018)
Table Global Acute Intermittent Porphyria Value Market Share by Application (2013-2018)
Figure Global Acute Intermittent Porphyria Value Market Share by Application (2013-2018)
Table Global Acute Intermittent Porphyria Sale Price by Application (2013-2018)
Table Global Acute Intermittent Porphyria Sales by Players (2016-2018) (K Units)
Table Global Acute Intermittent Porphyria Sales Market Share by Players (2016-2018)
Figure Global Acute Intermittent Porphyria Sales Market Share by Players in 2016
Figure Global Acute Intermittent Porphyria Sales Market Share by Players in 2017
Table Global Acute Intermittent Porphyria Revenue by Players (2016-2018) ($ Millions)
Table Global Acute Intermittent Porphyria Revenue Market Share by Players (2016-2018)
Figure Global Acute Intermittent Porphyria Revenue Market Share by Players in 2016
Figure Global Acute Intermittent Porphyria Revenue Market Share by Players in 2017
Table Global Acute Intermittent Porphyria Sale Price by Players (2016-2018)
Figure Global Acute Intermittent Porphyria Sale Price by Players in 2017
Table Global Acute Intermittent Porphyria Manufacturing Base Distribution and Sales Area by Players
Table Players Acute Intermittent Porphyria Products Offered
Table Acute Intermittent Porphyria Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Acute Intermittent Porphyria Consumption by Regions 2013-2018 (K Units)
Table Global Acute Intermittent Porphyria Consumption Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Consumption Market Share by Regions 2013-2018
Table Global Acute Intermittent Porphyria Value by Regions 2013-2018 ($ Millions)
Table Global Acute Intermittent Porphyria Value Market Share by Regions 2013-2018
Figure Global Acute Intermittent Porphyria Value Market Share by Regions 2013-2018
Figure Americas Acute Intermittent Porphyria Consumption 2013-2018 (K Units)
Figure Americas Acute Intermittent Porphyria Value 2013-2018 ($ Millions)
Figure APAC Acute Intermittent Porphyria Consumption 2013-2018 (K Units)
Figure APAC Acute Intermittent Porphyria Value 2013-2018 ($ Millions)
Figure Europe Acute Intermittent Porphyria Consumption 2013-2018 (K Units)
Figure Europe Acute Intermittent Porphyria Value 2013-2018 ($ Millions)
Figure Middle East & Africa Acute Intermittent Porphyria Consumption 2013-2018 (K Units)
Figure Middle East & Africa Acute Intermittent Porphyria Value 2013-2018 ($ Millions)
Table Americas Acute Intermittent Porphyria Consumption by Countries (2013-2018) (K Units)
Table Americas Acute Intermittent Porphyria Consumption Market Share by Countries (2013-2018)
Figure Americas Acute Intermittent Porphyria Consumption Market Share by Countries in 2017
Table Americas Acute Intermittent Porphyria Value by Countries (2013-2018) ($ Millions)
Table Americas Acute Intermittent Porphyria Value Market Share by Countries (2013-2018)
Figure Americas Acute Intermittent Porphyria Value Market Share by Countries in 2017
Table Americas Acute Intermittent Porphyria Consumption by Type (2013-2018) (K Units)
Table Americas Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Figure Americas Acute Intermittent Porphyria Consumption Market Share by Type in 2017
Table Americas Acute Intermittent Porphyria Consumption by Application (2013-2018) (K Units)
Table Americas Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Figure Americas Acute Intermittent Porphyria Consumption Market Share by Application in 2017
Figure United States Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure United States Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Canada Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Canada Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Mexico Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Mexico Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Table APAC Acute Intermittent Porphyria Consumption by Countries (2013-2018) (K Units)
Table APAC Acute Intermittent Porphyria Consumption Market Share by Countries (2013-2018)
Figure APAC Acute Intermittent Porphyria Consumption Market Share by Countries in 2017
Table APAC Acute Intermittent Porphyria Value by Countries (2013-2018) ($ Millions)
Table APAC Acute Intermittent Porphyria Value Market Share by Countries (2013-2018)
Figure APAC Acute Intermittent Porphyria Value Market Share by Countries in 2017
Table APAC Acute Intermittent Porphyria Consumption by Type (2013-2018) (K Units)
Table APAC Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Figure APAC Acute Intermittent Porphyria Consumption Market Share by Type in 2017
Table APAC Acute Intermittent Porphyria Consumption by Application (2013-2018) (K Units)
Table APAC Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Figure APAC Acute Intermittent Porphyria Consumption Market Share by Application in 2017
Figure China Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure China Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Japan Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Japan Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Korea Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Korea Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure India Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure India Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Australia Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Australia Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Table Europe Acute Intermittent Porphyria Consumption by Countries (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Consumption Market Share by Countries (2013-2018)
Figure Europe Acute Intermittent Porphyria Consumption Market Share by Countries in 2017
Table Europe Acute Intermittent Porphyria Value by Countries (2013-2018) ($ Millions)
Table Europe Acute Intermittent Porphyria Value Market Share by Countries (2013-2018)
Figure Europe Acute Intermittent Porphyria Value Market Share by Countries in 2017
Table Europe Acute Intermittent Porphyria Consumption by Type (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Figure Europe Acute Intermittent Porphyria Consumption Market Share by Type in 2017
Table Europe Acute Intermittent Porphyria Consumption by Application (2013-2018) (K Units)
Table Europe Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Figure Europe Acute Intermittent Porphyria Consumption Market Share by Application in 2017
Figure Germany Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Germany Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure France Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure France Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure UK Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure UK Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Italy Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Italy Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Russia Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Russia Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Spain Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Spain Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Acute Intermittent Porphyria Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Countries in 2017
Table Middle East & Africa Acute Intermittent Porphyria Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Acute Intermittent Porphyria Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Acute Intermittent Porphyria Value Market Share by Countries in 2017
Table Middle East & Africa Acute Intermittent Porphyria Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Type in 2017
Table Middle East & Africa Acute Intermittent Porphyria Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Acute Intermittent Porphyria Consumption Market Share by Application in 2017
Figure Egypt Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Egypt Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure South Africa Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure South Africa Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Israel Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Israel Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure Turkey Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure Turkey Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Acute Intermittent Porphyria Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Acute Intermittent Porphyria Value Growth 2013-2018 ($ Millions)
Table Acute Intermittent Porphyria Distributors List
Table Acute Intermittent Porphyria Customer List
Figure Global Acute Intermittent Porphyria Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Acute Intermittent Porphyria Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Acute Intermittent Porphyria Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Acute Intermittent Porphyria Consumption Market Forecast by Regions
Table Global Acute Intermittent Porphyria Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Acute Intermittent Porphyria Value Market Share Forecast by Regions
Figure Americas Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Americas Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure APAC Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure APAC Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Europe Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Europe Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Middle East & Africa Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Middle East & Africa Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure United States Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure United States Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Canada Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Canada Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Mexico Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Mexico Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Brazil Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Brazil Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure China Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure China Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Japan Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Japan Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Korea Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Korea Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Southeast Asia Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Southeast Asia Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure India Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure India Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Australia Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Australia Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Germany Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Germany Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure France Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure France Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure UK Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure UK Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Italy Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Italy Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Russia Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Russia Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Spain Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Spain Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Egypt Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Egypt Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure South Africa Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure South Africa Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Israel Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Israel Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure Turkey Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure Turkey Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Figure GCC Countries Acute Intermittent Porphyria Consumption 2018-2023 (K Units)
Figure GCC Countries Acute Intermittent Porphyria Value 2018-2023 ($ Millions)
Table Global Acute Intermittent Porphyria Consumption Forecast by Type (2018-2023) (K Units)
Table Global Acute Intermittent Porphyria Consumption Market Share Forecast by Type (2018-2023)
Table Global Acute Intermittent Porphyria Value Forecast by Type (2018-2023) ($ Millions)
Table Global Acute Intermittent Porphyria Value Market Share Forecast by Type (2018-2023)
Table Global Acute Intermittent Porphyria Consumption Forecast by Application (2018-2023) (K Units)
Table Global Acute Intermittent Porphyria Consumption Market Share Forecast by Application (2018-2023)
Table Global Acute Intermittent Porphyria Value Forecast by Application (2018-2023) ($ Millions)
Table Global Acute Intermittent Porphyria Value Market Share Forecast by Application (2018-2023)
Table Dahaner Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Dahaner Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Dahaner Acute Intermittent Porphyria Market Share (2016-2018)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Roche Acute Intermittent Porphyria Market Share (2016-2018)
Table Bio-Rad Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bio-Rad Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bio-Rad Laboratories Acute Intermittent Porphyria Market Share (2016-2018)
Table Siemens Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Siemens Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Siemens Acute Intermittent Porphyria Market Share (2016-2018)
Table ARKRAY Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ARKRAY Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ARKRAY Acute Intermittent Porphyria Market Share (2016-2018)
Table Sysmex Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sysmex Corporation Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sysmex Corporation Acute Intermittent Porphyria Market Share (2016-2018)
Table ACON Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table ACON Laboratories Acute Intermittent Porphyria Sales, Revenue, Price and Gross Margin (2016-2018)
Figure ACON Laboratories Acute Intermittent Porphyria Market Share (2016-2018)


More Publications